Stella S.
- Country
- Italy
- Department
- Hematology
Research Overview
- Evaluation of Allogeneic Hematopoietic Stem Cell Transplantation with Azacitidine Versus Conventional Chemotherapy in High-Risk Myelodysplastic Syndromes
- Phase II Evaluation of Venetoclax and Decitabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Eligible for Allogeneic Stem Cell Transplantation
Data & Insights
Has run more than one trial at 6 of 46 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes, with particular focus on innovative therapeutic approaches for elderly patients.
- Blood Disorders Management
- Leukemia Treatment
- Myelodysplastic Syndromes
The investigator demonstrates expertise in hematologic conditions affecting bone marrow function and blood cell production.
Transplantation Medicine
The investigator has significant experience in hematopoietic stem cell transplantation (HSCT) procedures, particularly focusing on their application in treating blood disorders.
- Stem Cell Transplantation
- Transplant Eligibility Assessment
- Post-Transplant Care
Their work encompasses evaluating transplantation feasibility in various patient populations and conditions.
Therapeutic Innovation
The investigator explores novel therapeutic combinations including chemotherapy-free approaches and hypomethylating treatments for hematologic conditions.
- Novel Drug Combinations
- Treatment Protocol Development
- Elderly Patient Care
Their focus includes developing treatment strategies for specific patient populations, particularly elderly individuals with blood disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.